| Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease JH Lee, D Kim, HJ Kim, CH Lee, JI Yang, W Kim, YJ Kim, JH Yoon, ... Digestive and liver disease 42 (7), 503-508, 2010 | 1239 | 2010 |
| Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States D Kim, RW Kim, HJ Kim, TM Therneau Hepatology 57 (4), 1357-1365, 2013 | 836 | 2013 |
| Clinical epidemiology and disease burden of nonalcoholic fatty liver disease BJ Perumpail, MA Khan, ER Yoo, G Cholankeril, D Kim, A Ahmed World journal of gastroenterology 23 (47), 8263, 2017 | 782 | 2017 |
| Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis BK Koo, D Kim, SK Joo, JH Kim, MS Chang, BG Kim, KL Lee, W Kim Journal of hepatology 66 (1), 123-131, 2017 | 385 | 2017 |
| Nonobese fatty liver disease D Kim, WR Kim Clinical gastroenterology and hepatology 15 (4), 474-485, 2017 | 368 | 2017 |
| Nonalcoholic fatty liver disease is associated with coronary artery calcification D Kim, SY Choi, EH Park, W Lee, JH Kang, W Kim, YJ Kim, JH Yoon, ... Hepatology 56 (2), 605-613, 2012 | 367 | 2012 |
| Non-alcoholic fatty liver disease across the spectrum of hypothyroidism GE Chung, D Kim, W Kim, JY Yim, MJ Park, YJ Kim, JH Yoon, HS Lee Journal of hepatology 57 (1), 150-156, 2012 | 360 | 2012 |
| Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States D Kim, P Konyn, KK Sandhu, BB Dennis, AC Cheung, A Ahmed Journal of hepatology 75 (6), 1284-1291, 2021 | 276 | 2021 |
| Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography D Kim, WR Kim, JA Talwalkar, HJ Kim, RL Ehman Radiology 268 (2), 411-419, 2013 | 270 | 2013 |
| Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case–control study of 7078 Koreans undergoing health check-ups SJ Chung, D Kim, MJ Park, YS Kim, JS Kim, HC Jung, IS Song Gut 57 (10), 1360-1365, 2008 | 269 | 2008 |
| High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: early experience from California G Cholankeril, A Podboy, VI Aivaliotis, B Tarlow, EA Pham, S Spencer, ... Gastroenterology 159 (2), 775-777, 2020 | 263* | 2020 |
| Nonalcoholic fatty liver disease and metabolic syndrome D Kim, A Touros, WR Kim Clinics in liver disease 22 (1), 133-140, 2018 | 237 | 2018 |
| Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016 D Kim, AA Li, C Gadiparthi, MA Khan, G Cholankeril, JS Glenn, A Ahmed Gastroenterology 155 (4), 1154-1163. e3, 2018 | 213 | 2018 |
| Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study D Kim, N Adeniji, N Latt, S Kumar, PP Bloom, ES Aby, P Perumalswami, ... Clinical Gastroenterology and Hepatology 19 (7), 1469-1479. e19, 2021 | 212 | 2021 |
| Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans SJ Chung, YS Kim, SY Yang, JH Song, D Kim, MJ Park, SG Kim, IS Song, ... Gut 60 (11), 1537-1543, 2011 | 203 | 2011 |
| Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity MS Kwak, D Kim The Korean journal of internal medicine 33 (1), 64, 2018 | 198 | 2018 |
| Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study H Kwon, D Kim, JS Kim Scientific reports 7 (1), 10955, 2017 | 195 | 2017 |
| Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case–control study HW Kang, D Kim, HJ Kim, CH Kim, YS Kim, MJ Park, JS Kim, SH Cho, ... The American journal of gastroenterology 105 (1), 178-187, 2010 | 193 | 2010 |
| KASL clinical practice guidelines: management of nonalcoholic fatty liver disease SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim, TH Lee, BK Jang, SG Kim, ... Clinical and molecular hepatology 27 (3), 363, 2021 | 183 | 2021 |
| Visceral adipose tissue area is an independent risk factor for hepatic steatosis BJ Park, YJ Kim, DH Kim, W Kim, YJ Jung, JH Yoon, CY Kim, YM Cho, ... Journal of gastroenterology and hepatology 23 (6), 900-907, 2008 | 183 | 2008 |
